Kronox Lab Sciences Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target

Kronox Lab Sciences CMP Rs.144. Market cap Rs.561 Cr. PE Not meaningful. 12-month target Rs.145-164.

Updated: 9 Jul 2026 • 1:22 pm

Posted by:

Kronox Lab Sciences Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target

Kronox Lab Sciences Q1 Results FY27 is coming into focus as investors position ahead of the July-August 2026 results season, with Kronox Lab Sciences shares trading at Rs.144 against a market capitalisation of Rs.561 Cr and a price-to-earnings multiple of Not meaningful. As a specialty chemicals name on the NSE and BSE, Kronox Lab Sciences enters the Kronox Lab Sciences Q1 Results FY27 print with the Street watching revenue momentum, margin trajectory and management commentary on FY27 guidance.

Quarterly financials for Kronox Lab Sciences are not yet fully available on Univest’s data partners for this cycle; investors should track Screener.in and the NSE/BSE filings directly for the Kronox Lab Sciences Q1 Results FY27 result date and cross-check any figures before making investment decisions.

Get Free Investment Predictions and Kronox Lab Sciences Research at Univest

Kronox Lab Sciences (NSE: KRONOX) operates in the specialty chemicals space and is tracked on Univest under its NSE and BSE listings ahead of the Kronox Lab Sciences Q1 Results FY27 season, forming the base against which the Kronox Lab Sciences Q1 Results FY27 estimates in this article are built. This Kronox Lab Sciences Q1 Results FY27 snapshot is intended as a starting point for research, not a substitute for the company’s own disclosures.

Table of Contents

Kronox Lab Sciences Q1 FY27 Estimates

Metric	Detail
CMP	Rs.144
Market Cap	Rs.561 Cr
Results Date	July-August 2026 (indicative)
12-Month Target (Uniresearch Estimate)	Rs.145-164

Univest, a SEBI-Registered Investment Advisor, Tracks Kronox Lab Sciences Ahead of Q1 FY27 Results

Key Catalysts to Watch

1. Realisation Stabilisation

Stabilising realisations after recent price volatility in key product segments is one of the primary variables that analysts are tracking ahead of Kronox Lab Sciences’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Kronox Lab Sciences share price target or faces renewed pressure.

2. Volume Growth

Volume growth from capacity utilisation improvement across manufacturing units is one of the primary variables that analysts are tracking ahead of Kronox Lab Sciences’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Kronox Lab Sciences share price target or faces renewed pressure.

3. Export Demand

Export demand recovery supporting topline in key specialty chemical categories is one of the primary variables that analysts are tracking ahead of Kronox Lab Sciences’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Kronox Lab Sciences share price target or faces renewed pressure.

Download the Univest iOS App or Univest Android App to track Kronox Lab Sciences’s live price and Q1 FY27 result updates.

Key Risks to the Kronox Lab Sciences Q1 Results FY27 Outlook

Realisation volatility from global oversupply or demand softness.
Input cost pressure from crude-linked or key raw material price swings.
Regulatory or environmental compliance costs affecting margins.

Recent Performance Context

Detailed recent-quarter financials for Kronox Lab Sciences were not available from Univest’s data partners at the time of writing. Investors should check Screener.in or the company’s exchange filings for the latest verified numbers before the Q1 FY27 results.

Technical Analysis Ahead of Kronox Lab Sciences Q1 Results FY27

Kronox Lab Sciences shares last traded at Rs.144. For the current 52-week high and low, support and resistance levels, investors should check the live chart on the Univest app or the NSE website, since these levels move intraday and are not reproduced here to avoid stale data.

Share Price Target Based on the Kronox Lab Sciences Q1 Results FY27 Outlook

3-6 Month Target

Over a 3-6 month horizon, the Kronox Lab Sciences Q1 Results FY27 trailing-growth framework points to a range of Rs.141-153 for Kronox Lab Sciences, contingent on the Kronox Lab Sciences Q1 Results FY27 print matching or beating the trailing growth trend.

12-Month Target

The 12-month target (Uniresearch estimate) tied to this Kronox Lab Sciences Q1 Results FY27 view for Kronox Lab Sciences works out to Rs.145-164, built on the same trailing revenue growth trend and current valuation multiple. Tracking is how Univest research categorises the stock heading into Kronox Lab Sciences Q1 Results FY27, not a formal Buy or Sell call.

FY27-28 Outlook

Looking out to FY27-28, a sustained continuation of the growth trajectory implied by this Kronox Lab Sciences Q1 Results FY27 analysis would put Kronox Lab Sciences in a Rs.154-179 range, though this is sensitive to sector-wide demand, cost trends and any change in the company’s competitive position.

What to Watch in the Kronox Lab Sciences Q1 Results FY27 Print

Revenue and PAT versus the Kronox Lab Sciences Q1 Results FY27 estimate range in this preview.
Management commentary on FY27 growth guidance and margin trajectory relevant to the Kronox Lab Sciences Q1 Results FY27 narrative.
Stabilising realisations after recent price volatility in key product segments
Realisation volatility from global oversupply or demand softness

Conclusion on Kronox Lab Sciences Q1 Results FY27

Kronox Lab Sciences enters the Q1 FY27 results season trading at Rs.144, with the 12-month Uniresearch target range of Rs.145-164 reflecting a tracking stance. Investors tracking the Kronox Lab Sciences Q1 Results FY27 print should watch the catalysts and risks above and consult a SEBI-registered advisor before making investment decisions around the results.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Kronox Lab Sciences Q1 Results FY27

When are Kronox Lab Sciences Q1 FY27 results expected?

Ans. Kronox Lab Sciences’s Q1 FY27 results are expected in the July-August 2026 window, in line with the broader NSE and BSE results season for the quarter ending June 2026.

What is the Kronox Lab Sciences Q1 FY27 revenue estimate?

Ans. Detailed quarterly estimates are not available for Kronox Lab Sciences at this time; check Screener.in or the company’s exchange filings for verified numbers.

What is the Kronox Lab Sciences share price target?

Ans. The 12-month Uniresearch estimate for Kronox Lab Sciences share price target is Rs.145-164, based on trailing growth and current valuation multiples.

Is Kronox Lab Sciences a good buy before Q1 FY27 results?

Ans. Kronox Lab Sciences is tracking heading into Q1 FY27 results. Investors should weigh the catalysts and risks in this article and consult a SEBI-registered advisor before investing.

What should investors watch in Kronox Lab Sciences’s Q1 FY27 results?

Ans. Key items include revenue and PAT versus estimates, management commentary on FY27 guidance, and stabilising realisations after recent price volatility in key product segments.